Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
about
The homeobox only protein homeobox (HOPX) and colorectal cancerThe somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cellsMicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistanceClinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer.Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.Transcriptional profiling of ErbB signalling in mammary luminal epithelial cells--interplay of ErbB and IGF1 signalling through IGFBP3 regulation.MS-based glycomic strategies for probing the structural details of polylactosaminoglycan chain on N-glycans and glycoproteomic identification of its protein carriers.Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs.Integrating comparative expression profiling data and association of SNPs with Salmonella shedding for improved food safety and porcine disease resistance.Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaaGene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic ArthritisExpression biomarkers for clinical efficacy and outcome prediction in cancer.Therapeutic resistance in lung cancer.Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin.Claudin-20 promotes an aggressive phenotype in human breast cancer cells.Positive selection on apoptosis related genes.The testicular germ cell tumour transcriptome.Array-based pharmacogenomics of molecular-targeted therapies in oncology.EMP-1 promotes tumorigenesis of NSCLC through PI3K/AKT pathway.Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation.Identity crisis in the PMP-22/EMP/MP20/Claudin superfamily (Pfam00822).Down-regulation of EMP1 is associated with epithelial hyperplasia and metaplasia in nasal polyps.[Molecular factors related to gefitinib efficacy in advanced non-small cell lung cancer].EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion.The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells.Pharmacogenomics steps toward personalized medicine
P2860
Q27004699-FD360D47-D903-4788-AF87-B6EA1CED630EQ28484664-5097CF14-E266-480F-A80F-ADB8BA57873BQ28538690-88635B0C-79F3-41C4-86D3-D3560DF0EDDDQ33279462-FD797FB6-E2C5-4E0B-8AC5-1D39A23F067DQ33491567-575D9F7A-6B8F-4367-A2E9-2A0B2EC3624FQ33692428-1B3B452F-0EEE-4ECA-B9AD-456D6A814537Q33927737-BB35A5FA-1D6D-4ECA-A22F-1D6D00C60422Q33939820-05087FA7-D88C-4BAE-92F0-104CC2755C4CQ34015145-C252DFA0-8295-4B21-9A3F-2F80BE6E3F02Q34182374-2168F02D-2D7B-4455-A070-6B3D9FDB8AABQ35667354-BC7DA446-3610-4334-953D-DE7FB5605B77Q36341754-C832A4E5-9DB6-4974-8B61-0149F294F45BQ36609767-8376205F-61F5-46F8-B39B-4CD60A5ACD20Q37293935-84800AAC-060B-4AAB-AB03-13242494D474Q37399393-E6EC508C-23A2-4070-AF9F-550C632DCCF3Q37660670-3AB18769-A482-46A8-AA27-8AAA3B1BE518Q37886262-A937036C-8E16-4CC4-ADB4-E00BBC7E66B1Q37976288-A535FC3D-843D-4CE9-AD25-BF9451B73E16Q39220097-7A9839AE-5A91-448C-8F34-67A848150E43Q40176065-08DE7EEA-120C-48D0-9696-0AA856EB0E8EQ41991528-525E51A6-D012-41B8-87AB-289E7BE45C19Q42444732-00F398A2-3857-469B-9A7E-57BD8A860386Q42951192-ECDBDA76-515F-409C-BF2E-64D31276055CQ53062739-C5E49D85-A971-4F63-882C-B03D859F4727Q55454960-0B200AD7-CFE8-4542-BC50-5681D0A00ABBQ56446183-BE6CB84F-889F-4D19-9B19-D3B622E484C3
P2860
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Epithelial membrane protein-1 is a biomarker of gefitinib resistance
@nl
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@ast
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en-gb
type
label
Epithelial membrane protein-1 is a biomarker of gefitinib resistance
@nl
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@ast
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en-gb
prefLabel
Epithelial membrane protein-1 is a biomarker of gefitinib resistance
@nl
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@ast
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en
Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
@en-gb
P2093
P2860
P356
P1476
Epithelial membrane protein-1 is a biomarker of gefitinib resistance
@en
P2093
Anjali Jain
Anna Galkin
Charles A Tindell
Daniel E Afar
David B Agus
Isett Laux
John Curran
Nina Aronson
Ronald B Natale
Steven Shak
P2860
P304
11858-11863
P356
10.1073/PNAS.0502113102
P407
P577
2005-08-08T00:00:00Z